Mifepristone Tablets 200mg (3tabs/box)

• Customization: Available
• Dossier: Ctd
• Transport Package: Free
• Model NO.: tablets
• Specification: 200mg
• Trademark: Sinolead
• Origin: China

Product Description

 

Basic Info.

 

Generic Name	Mifepristone Tablets 200mg
Strength	200mg
Packing	3tabs/box
Origin	China

Component:
Mifepristone.

Character:

This product is yellowish, odorless and tasteless.

Indications:

Mifepristone tablets are used in sequential combination with prostaglandin drugs to terminate a pregnancy within 49 days of menopause.
 

Usage and dosage:

Healthy early pregnant women with ≤49 days of menopause should take 25mg ~ 50mg (1 ~ 2 tablets) of mifepristone orally, twice a day for 2 ~ 3 days, with a total of 150mg (6 tablets), and fast for 2 hours after each medication. On the 3rd to 4th day, misoprostol 600μg (200μg/tablet ×3 tablets) was taken orally in the morning or a methyl carbprost suppository (1mg) was placed in the posterior fornix of the vagina. Bed rest 1 ~ 2 hours, outpatient observation 6 hours. Pay attention to bleeding after medication, whether there is pregnancy product discharge and side effects.

Matters needing attention:

1. Confirmed as early pregnancy, the number of days should not exceed 49 days, the shorter the pregnancy, the better the effect.

2. Mifepristone tablets must be used in the context of emergency, curettage, infusion and blood transfusion. This drug must not be sold in pharmacies.

3. Before taking the drug, the user must be informed of the treatment effect and possible side effects in detail. If there is heavy bleeding or other abnormal conditions during treatment or follow-up, seek medical attention promptly.

4. After taking the drug, there will generally be a small amount of vaginal bleeding earlier, and some women will bleed for a longer time after abortion. A small number of early pregnant women who take mifepristone tablets can naturally abort. About 80% of pregnant women discharge the villus sac within 6 hours after using prostaglandins, and about 10% of pregnant women discharge pregnancy matter within a week after taking the drug.

5. 8 to 15 days after taking the drug should be returned to the original treatment unit to determine the abortion effect. If necessary, B-type ultrasound examination or blood HCG determination, if confirmed as incomplete abortion or continued pregnancy, should be treated in time.

6. The use of this product to terminate early pregnancy failure, must be induced abortion termination of pregnancy.